WuXi AppTec to Contest Designation as Chinese Military Company Under Biosecure Act

WuXi AppTec announced its intention to contest its designation as a Chinese military company following the implementation of the Biosecure Act. The company’s legal challenge marks a significant development in the ongoing regulatory scrutiny surrounding Chinese biotechnology firms operating within the United States market.

The Biosecure Act restricts federal agencies from contracting with specific biotechnology providers deemed to pose national security risks. In response to its inclusion on the restricted list, WuXi AppTec maintains that it does not meet the criteria for a Chinese military company and intends to pursue formal avenues to dispute the classification. This development highlights the broader implications of the legislation, as pharmaceutical and biotech companies continue to assess their supply chains and partnerships in light of the new federal requirements.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 9, 2026

Author

GOAI